Intraarterial Infusion Of Erbitux and Bevacizumab For Relapsed/Refractory Intracranial Glioma In Patients Under 22

NCT01884740 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

13

Enrollment

OTHER

Sponsor class

Stopped The study was prematurely closed in December 2021 due to low accrual.

Conditions

Glioblastoma Multiforme
Fibrillary Astrocytoma of Brain
Glioma of Brainstem
Anaplastic Astrocytoma
Pilomyxoid Astrocytoma
Mixed Oligodendroglioma-Astrocytoma
Brain Stem Glioma
Diffuse Intrinsic Pontine Glioma

Interventions

DRUG: SIACI of Erbitux and Bevacizumab

Sponsor

Weill Medical College of Cornell University